Edition:
United Kingdom

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

4.28USD
20 Jul 2018
Change (% chg)

$0.06 (+1.42%)
Prev Close
$4.22
Open
$4.24
Day's High
$4.50
Day's Low
$4.20
Volume
11,447
Avg. Vol
17,300
52-wk High
$15.34
52-wk Low
$4.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.515
FY 2017 Dec '17 0.00 -0.466
Sep '17 0.00 -0.425
Jun '17 0.00 -0.336
Mar '17 0.00 -0.311
FY 2016 Dec '16 0.00 -0.303
Sep '16 0.00 -0.288
Jun '16 0.00 -0.377
Mar '16 0.00 -0.268
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 --
Quarter Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 4 -0.56 -0.49 -0.62 --
Quarter Ending Dec-18 4 -0.57 -0.46 -0.67 --
Year Ending Dec-18 4 -2.18 -1.95 -2.38 --
Year Ending Dec-19 4 -2.67 -2.11 -3.92 --
LT Growth Rate (%) 1 1.20 1.20 1.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 112.52 5.73
Price to Book (MRQ) -- 15.54 5.47
Price to Tangible Book (MRQ) 22.32 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 37.48 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 79.88 5.64
Sales - 5 Yr. Growth Rate -- 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.99 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago -13.60 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate -- 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 2.19 5.50 3.03
LT Debt to Equity (MRQ) 0.00 34.92 12.51
Total Debt to Equity (MRQ) 0.00 36.72 16.84
Interest Coverage (TTM) -- -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.68 54.37
Gross Margin - 5 Yr. Avg. -- 50.98 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -586.56 10.81
Operating Margin (TTM) -- -733.21 4.58
Operating Margin - 5 Yr. Avg. -- -608.15 6.23
Pre-Tax Margin (TTM) -- -707.36 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -611.67 6.67
Net Profit Margin (TTM) -- -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -- -614.69 2.94
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,025,841 860,394,083
Net Income/Employee (TTM) -1,209,600 3,117,868 101,209,433
Receivable Turnover (TTM) -- 20.74 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.27 11.14
Return on Assets - 5 Yr. Avg. -- 3.72 12.40
Return on Investment (TTM) -- 2.22 14.61
Return on Investment - 5 Yr. Avg. -- 2.89 16.14
Return on Equity (TTM) -- 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -40.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aileron Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.66%
# of Holders: 47
Total Shares Held: 4,223,257
3 Mo. Net Change: -253,715
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.